EUVIMEDEUVIMED entdecken
Crossref

Evaluation of acetylcholinesterase and monoamine oxidase inhibitory activities of the aqueous extract and flavonoids of Capparis cartilaginea Decne

B Alsharif, M Biasiotti, G P Davey, C Cavaleiro, F Boylan

Planta Medica · 01.03.2026 · 92 (03) · 229

DOI: 10.1055/s-0045-1814941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von B Alsharif und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Capparis cartilaginea Decne . (Capparaceae) is a medicinal plant with a long history of use in traditional medicine. Despite its ethnopharmacological relevance, its neuropharmacological properties remain underexplored . In our previous work, seven glycosylated flavonoids were isolated and structurally elucidated from the aqueous leaf extract, including derivatives of kaempferol, quercetin, and isorhamnetin [ 1 ]. In the present study, the neuropharmacological potential of the aqueous extract and selected flavonoids was evaluated through the inhibition of acetylcholinesterase (AChE), monoamine oxidase A (MAO-A), and monoamine oxidase B (MAO-B), enzymes associated with neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. The aqueous extract exhibited no significant inhibitory activity against AChE at concentrations ranging from 0.005 to 0.5 mg/mL. In contrast, both the extract and isolated flavonoids showed concentration-dependent inhibition of MAO-A and MAO-B, with a markedly greater effect on MAO-B. The inhibition was observed in the range of 0.01 to 2 mg/mL. Based on their selective MAO-B inhibitory profiles, four flavonoids were selected for enzyme kinetics analysis: kaempferol-3- O -rutinoside (nicotiflorin), quercetin-3- O -rutinoside (rutin), quercetin 3-(2G-rhamnosylrutinoside) (manghaslin), and isorhamnetin-3- O -rutinoside (narcissin). These compounds demonstrated inhibition constants (Ki) in the nanomolar range, indicating potent and selective inhibition of MAO-B. These findings suggest potential pharmacological value and support further research into their application in neurological disorders. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Alsharif, B., Biasiotti, M., Davey, G. P., Cavaleiro, C., & Boylan, F. (2026). Evaluation of acetylcholinesterase and monoamine oxidase inhibitory activities of the aqueous extract and flavonoids of Capparis cartilaginea Decne. Planta Medica, 92(03), 229. https://doi.org/10.1055/s-0045-1814941

Vancouver

Alsharif B, Biasiotti M, Davey GP, Cavaleiro C, Boylan F. Evaluation of acetylcholinesterase and monoamine oxidase inhibitory activities of the aqueous extract and flavonoids of Capparis cartilaginea Decne. Planta Medica. 2026;92(03):229. doi:10.1055/s-0045-1814941

BibTeX
@article{Alsharif2026,
  author = {Alsharif, B and Biasiotti, M and Davey, G P and Cavaleiro, C and Boylan, F},
  title = {Evaluation of acetylcholinesterase and monoamine oxidase inhibitory activities of the aqueous extract and flavonoids of Capparis cartilaginea Decne},
  journal = {Planta Medica},
  year = {2026},
  volume = {92},
  number = {03},
  pages = {229},
  doi = {10.1055/s-0045-1814941}
}
Kostenlos starten →